FFAI Surges 50% After Analyst EPS Upgrade Leads Industrial, Healthcare Reversals
Faraday Future (FFAI) led today's movers with a 50% gain after analysts revised EPS growth estimates 12.9 percentage points higher to 63.2%, signaling improved capital efficiency in EV operations. Keel Infrastructure (KEEL) gained 34.3% on 43.7% EPS growth projections, while Travere Therapeutics (TVTX) surged 29.8% following a 29.1pp EPS revision to 548.8%—the largest proportional estimate upgrade of the session. Bloom Energy (BE) added 27.4% with the Oracle AI data center power deal providing a concrete news catalyst that reinforced its 108.4% EPS forecast.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| FFAI | Consumer Cyclical | 2026-04-06 | +12.9pp | +50.0% |
| KEEL | Industrials | 2026-04-06 | N/A | +34.3% |
| CAR | Industrials | 2026-04-06 | +4.1pp | +30.6% |
| TVTX | Healthcare | 2026-04-08 | +29.1pp | +29.8% |
| BE | Industrials | 2026-04-09 | +1.5pp | +27.4% |
FFAI — Faraday Future Intelligent Electric Inc
The 12.9 percentage-point upward revision in next-year EPS estimates—moving from 50.3% to 63.2%—caught the market underweight heading into what analysts now model as a meaningful inflection in Faraday Future's profitability trajectory. The 50% price surge from $0.22 to $0.33 reflects a rapid repricing as quantitative screens surfaced the revision before retail momentum took over. Without recent news, the move underscores how deeply discounted EV speculative names can gap violently when even modest analyst optimism arrives. The Consumer Cyclical sector's sensitivity to macro sentiment shifts likely amplified the technical breakout.
View screener snapshot from 2026-04-06 →KEEL — Keel Infrastructure Corp
Keel Infrastructure's 34.3% advance from $2.04 to $2.74 tracks directly with a 43.7% EPS growth projection that positions the name among the highest growth-rate estimates in the Industrials sector. The absence of news suggests institutional desks are positioning ahead of anticipated infrastructure spending cycles—potentially tied to government stimulus or private-sector capex acceleration. The move from sub-$2 to nearly $2.75 indicates a classic momentum re-rate where the screener flagged the estimate revision and algorithmic flow followed. KEEL's gain outpaces the broader industrials ETF performance for the same window.
View screener snapshot from 2026-04-06 →CAR — Avis Budget Group Inc
Avis Budget Group saw its next-year EPS estimate revise upward by 4.1 percentage points to 104.7%, and the market has rewarded the name with a 30.6% surge from $255.15 to $333.26. The travel and mobility sector has benefited from sustained demand for rental vehicles, and CAR's operating leverage likely improved as fleet utilization rates strengthened. The magnitude of the price move—roughly 7x the size of the EPS revision in percentage terms—indicates the estimate upgrade served as a confirmation signal for a pre-existing bullish technical setup. Fleet management cost assumptions may have been revised lower, improving the bottom-line outlook more than the top-line estimate suggests.
View screener snapshot from 2026-04-06 →TVTX — Travere Therapeutics Inc
Travere Therapeutics' EPS estimate surged from 519.7% to 548.8%—a 29.1 percentage-point upward revision that represents the most dramatic proportional estimate change of today's movers. The stock has climbed 29.8% from $31.68 to $41.11 in just six trading days, suggesting fundamental analysts have identified a meaningful improvement in the company's path to profitability. Healthcare names with expanding profit margins often trigger short-covering and momentum buying when estimates move, and TVTX's trajectory indicates the market is pricing in either commercial wins for existing products or favorable regulatory developments. The 548.8% growth rate signals near-breakeven economics transforming into meaningful earnings power.
View screener snapshot from 2026-04-08 →BE — Bloom Energy Corp
Bloom Energy's EPS estimate increased by 1.5 percentage points to 108.4%, but the headline catalyst driving the 27.4% surge from $160.13 to $204.01 was the Oracle agreement to purchase power for AI data centers. The news transformed a modest estimate revision into a narrative-driven momentum trade centered on the company's positioning in high-growth electricity demand from artificial intelligence infrastructure. Bloom's expansion of the Oracle deal provides concrete revenue visibility that reinforces the upgraded EPS forecast, creating a feedback loop where the fundamental catalyst and the technical breakout reinforce each other. The AI energy theme remains a dominant sector narrative attracting institutional capital.
View screener snapshot from 2026-04-09 →Today's movers are dominated by Industrials (3 of 5 names), suggesting capital is rotating into cyclicals with improving profitability forecasts. The diversity from Healthcare (TVTX) and Consumer Cyclical (FFAI) indicates the screener is catching breadth beyond a single sector narrative, with AI-adjacent energy (BE) standing out as the only name with a confirmed news catalyst reinforcing its analyst revision.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →